Stockreport

Lawsuits alleging GLP-1 drugs led to blindness to be centralized [Seeking Alpha]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF of lawsuits against Novo Nordisk ( NVO ) and Eli Lilly ( LLY ) that allege GLP-1 drugs used for type 2 diabetes and weight loss led to blindness. The Recommended For [Read more]